참고문헌
- Avilion AA, Piatyszek MA, Gupta J, et al (1996). Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res, 56, 645-50.
- Barclay JY, Morris A, Nwokolo CU (2005). Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol, 17, 221-7. https://doi.org/10.1097/00042737-200502000-00014
- Blackburn EH (2010). Telomeres and telomerase: the means to the end (Nobel lecture). Angew Chem Int Ed Engl, 49, 7405-21. https://doi.org/10.1002/anie.201002387
- Blasco MA, Rizen M, Greider CW, Hanahan D (1996). Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet, 12, 200-4. https://doi.org/10.1038/ng0296-200
- Bodnar AG, Ouellette M, Frolkis M, et al (1998). Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349-52. https://doi.org/10.1126/science.279.5349.349
- Canto MI, Setrakian S, Willis J, et al (2000). Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc, 51, 560-8.
- Clement G, Braunschweig R, Pasquier N, Bosman FT, Benhatter J (2006). Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patient at risk for malignant transformation. J Pathol, 208, 100-7. https://doi.org/10.1002/path.1884
- Dalbagni G, Han W, Zhang ZF, et al (1997). Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res, 3, 1593-8.
- Falk GW, Rice TW, Goldblum JR, Richter JE (1999). Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc, 49, 170-6. https://doi.org/10.1016/S0016-5107(99)70482-7
- Feng J, Funk WD, Wang SS, et al (1995). The RNA component of human telomerase. Science (New York), 269, 1236-41. https://doi.org/10.1126/science.7544491
- Going JJ, Fletcher-Monaghan AJ, Neilson L, et al (2004). Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in barrett's esophagus. Neoplasia, 6, 85-92.
- Harley CB, Kim NW (1996). Telomerase and cancer. Important Adv Oncol, 57-67.
- Kim NW, Piatyszek MA, Prowse KR, et al (1994). Specific association of human telomerase activity with immortal cells and cancer. Science (New York), 266, 2011-5. https://doi.org/10.1126/science.7605428
- Kim NW, Wu F (1997). Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res, 25, 2595-7. https://doi.org/10.1093/nar/25.13.2595
- Levine DS, Blount PL, Rudolph RE, Reid BJ (2000). Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol, 95, 1152-7. https://doi.org/10.1111/j.1572-0241.2000.02002.x
- Lord RV, Salonga D, Danenberg KD, et al (2000). Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg, 4, 135-42. https://doi.org/10.1016/S1091-255X(00)80049-9
- Luna RA, Gilbert E, Hunter JG (2012). High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Curr Opin Gastroenterol, 28, 362-9. https://doi.org/10.1097/MOG.0b013e328353e346
- Meyerson M, Counter CM, Eaton EN, et al (1997). hEST2, putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90, 785-95. https://doi.org/10.1016/S0092-8674(00)80538-3
- Milind R, Attwood SE (2012). Natural history of Barrett's esophagus. World J Gastroenterol, 18, 3483-91. https://doi.org/10.3748/wjg.v18.i27.3483
- Morales CP, Lee EL, Shay JW (1998). In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer, 83, 652-9. https://doi.org/10.1002/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M
- Nakayama JI, Tahara H, Tahara E, et al (1998). Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet, 18, 65-8. https://doi.org/10.1038/ng0198-65
- Ngamruengphong S, Sharma VK, Das A (2009). Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc, 69, 1021-8. https://doi.org/10.1016/j.gie.2008.06.056
- Pearson AS, Chiao P, Zhang L, et al (2000). The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration. Int J Oncol, 17, 381-5.
- Shammas MA, Qazi A, Batchu RB, et al (2008). Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo. Clin Cancer Res, 14, 4971-80. https://doi.org/10.1158/1078-0432.CCR-08-0473
- Shammas MA, Rao MY (2011). Purification of diseased cells from Barrett's esophagus and related lesions by laser capture microdissection. Methods Mol Biol, 755, 181-7. https://doi.org/10.1007/978-1-61779-163-5_14
- Shay JW, Wright WE (2011). Role of telomeres and telomerase in cancer. Semin Cancer Biol, 21, 349-53 https://doi.org/10.1016/j.semcancer.2011.10.001
- Takubo K, Nakamura K, Izumiyama N, et al (1997). Telomerase activity in esophageal carcinoma. J Surg Oncol, 66, 88-92. https://doi.org/10.1002/(SICI)1096-9098(199710)66:2<88::AID-JSO3>3.0.CO;2-H
- Wang DH, Souza RF (2011). Biology of Barrett's esophagus and esophageal adenocarcinoma. Gastrointest Endosc Clin N Am, 21, 25-38 https://doi.org/10.1016/j.giec.2010.09.011
- Wang KK, Sampliner RE (2008). Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol, 103, 788-97 https://doi.org/10.1111/j.1572-0241.2008.01835.x
- Zhang WW, Klotz L (2000). Telomerase activity in needle biopsies from prostate cancer and benign prostates: the influence of sampling bias. Eur J Clin Invest, 30, 275-6. https://doi.org/10.1046/j.1365-2362.2000.00637.x
- Zheng PS, Iwasaka T, Zhang ZM, Pater A, Sugimori H (2000). Telomerase activity in Papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses. Gyn Oncol, 77, 394-8. https://doi.org/10.1006/gyno.2000.5779
피인용 문헌
- Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer vol.11, pp.3, 2016, https://doi.org/10.3892/ol.2016.4188